In summary, our findings demonstrate that TACC3-PCAF competes with SIRT1 to bind c-Myc, enhancing its acetylation at K323 and thereby stabilizing c-Myc to promote colony formation and proliferation in bladder cancer. Here, KAT2B is linked to urinary bladder carcinoma.